Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response JM Cliff, JS Lee, N Constantinou, JE Cho, TG Clark, K Ronacher, EC King, ... The Journal of infectious diseases 207 (1), 18-29, 2013 | 273 | 2013 |
The human immune response to tuberculosis and its treatment: a view from the blood JM Cliff, SHE Kaufmann, H McShane, P van Helden, A O'Garra Immunological reviews 264 (1), 88-102, 2015 | 220 | 2015 |
Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis R Mistry, JM Cliff, CL Clayton, N Beyers, YS Mohamed, PA Wilson, ... The Journal of infectious diseases 195 (3), 357-365, 2007 | 180 | 2007 |
Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and … NN Chegou, JS Sutherland, S Malherbe, AC Crampin, PLAM Corstjens, ... Thorax 71 (9), 785-794, 2016 | 170 | 2016 |
Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosis N Andreu, J Phelan, PF de Sessions, JM Cliff, TG Clark, ML Hibberd Scientific reports 7 (1), 42225, 2017 | 137 | 2017 |
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects E Lachmandas, C Eckold, J Böhme, VACM Koeken, MB Marzuki, B Blok, ... The Journal of infectious diseases 220 (1), 139-150, 2019 | 105 | 2019 |
CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis Z Hasan, JM Cliff, HM Dockrell, B Jamil, M Irfan, M Ashraf, R Hussain PloS one 4 (12), e8459, 2009 | 97 | 2009 |
How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS L Nacul, S O'Boyle, L Palla, FE Nacul, K Mudie, CC Kingdon, JM Cliff, ... Frontiers in neurology 11, 826, 2020 | 81 | 2020 |
Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) JM Cliff, EC King, JS Lee, N Sepúlveda, AS Wolf, C Kingdon, E Bowman, ... Frontiers in immunology 10, 796, 2019 | 72 | 2019 |
Biogenesis of secretory organelles during B cell differentiation SJ Kirk, JM Cliff, JA Thomas, TH Ward Journal of leukocyte biology 87 (2), 245-255, 2010 | 69 | 2010 |
PD-1, PD-L1 and PD-L2 gene expression on T-cells and natural killer cells declines in conjunction with a reduction in PD-1 protein during the intensive phase of tuberculosis … SS Hassan, M Akram, EC King, HM Dockrell, JM Cliff PloS one 10 (9), e0137646, 2015 | 68 | 2015 |
CD40: a pivotal receptor in the determination of life/death decisions in B lymphocytes GGB Klaus, MSK Choi, EWF Lam, C Johnson-Leger, J Cliff International reviews of immunology 15 (1-2), 5-31, 1997 | 64 | 1997 |
Long-lived memory B-cell responses following BCG vaccination I Sebina, JM Cliff, SG Smith, S Nogaro, EL Webb, EM Riley, HM Dockrell, ... PloS one 7 (12), e51381, 2012 | 63 | 2012 |
Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis NN Chegou, JS Sutherland, AR Namuganga, PLAM Corstjens, A Geluk, ... Scientific reports 8 (1), 2675, 2018 | 54 | 2018 |
Extended Culture Enhances Sensitivity of a Gamma Interferon Assay for Latent Mycobacterium tuberculosis Infection A Cehovin, JM Cliff, PC Hill, RH Brookes, HM Dockrell Clinical and Vaccine Immunology 14 (6), 796-798, 2007 | 51 | 2007 |
Evidence of clinical pathology abnormalities in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) from an analytic cross-sectional study L Nacul, B de Barros, CC Kingdon, JM Cliff, TG Clark, K Mudie, ... Diagnostics 9 (2), 41, 2019 | 49 | 2019 |
Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment JM Cliff, JE Cho, JS Lee, K Ronacher, EC King, P Van Helden, G Walzl, ... The Journal of infectious diseases 213 (3), 485-495, 2016 | 47 | 2016 |
Differential gene expression identifies novel markers of CD4+ and CD8+ T cell activation following stimulation by Mycobacterium tuberculosis JM Cliff, INJ Andrade, R Mistry, CL Clayton, MG Lennon, AP Lewis, ... The Journal of Immunology 173 (1), 485-493, 2004 | 47 | 2004 |
Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis C Eckold, V Kumar, J Weiner, B Alisjahbana, AL Riza, K Ronacher, ... Clinical Infectious Diseases 72 (1), 69-78, 2021 | 40 | 2021 |
The UK ME/CFS biobank for biomedical research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis EM Lacerda, EW Bowman, JM Cliff, CC Kingdon, EC King, JS Lee, ... Open journal of bioresources 4, 2017 | 39 | 2017 |